|
Real-time
Other stock markets
|
||
| 2.112 EUR | +0.34% |
|
| Current month | -3.32% | ||
| 1 month | +5.45% |
Investment objective
The objective of the LS ARKG Genomic Tracker ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the Reference Asset), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.
Price |
Change |
5d. change |
Varia. Jan 1. |
Weight | ||
|---|---|---|---|---|---|---|
 | 80.82USD | +2.12% | -1.05% | +131.18% | 6.89% | |
| 101.50USD | +0.14% | +0.44% | +80.64% | 6.8% | |
| 56.68USD | -2.43% | -0.35% | +44.00% | 4.53% | |
| 7.550USD | -0.92% | -0.53% | -16.94% | 4.28% | |
| 9.020USD | -5.55% | -6.14% | -22.64% | 4.17% | |
| 20.56USD | +3.84% | +10.96% | -3.97% | 4.15% | |
| 27.36USD | -0.55% | +1.00% | +10.32% | 4.1% | |
| 18.05USD | -0.44% | +2.32% | -6.43% | 3.98% | |
| 1.150USD | +3.60% | +6.48% | -30.30% | 3.95% | |
More news
In partnership with
| Date | Price | Change |
|---|---|---|
| 25-12-15 | 2.112 € | +0.34% |
| 25-12-12 | 2.105 € | -1.12% |
| 25-12-11 | 2.129 € | -2.38% |
| 25-12-10 | 2.181 € | +0.52% |
| 25-12-09 | 2.170 € | -1.63% |
Other stock markets
Real-time Euronext Amsterdam
Last update December 15, 2025 at 03:04 am EST
More quotesDescription
| XS2399368062 | |
|---|---|
| Total Expense Ratio | 0.35% |
| Asset Class | Equities |
| Sector | |
| Size | |
| Currency | |
| Provider |
Features and characteristics
| Dividend Policy | Capitalisation |
|---|---|
| Jurisdiction | |
| Fund Structure | |
| Date of creation |
2021-12-13
|
| Geographical Focus |
AuM evolution ( 2025-10-30 )
| AuM (EUR) | 1 M€ |
|---|---|
| AuM 1M | 1 M€ |
| AuM 3 months | 1 M€ |
| AuM 6 months | 1 M€ |
| AuM 12 months | 1 M€ |
- Stock Market
- ETF
- ARKC ETF
Select your edition
All financial news and data tailored to specific country editions
